LuvAminos
ProductsResearchAffiliate ProgramContact us
Luvaminos

Research-grade peptides for laboratory and in-vitro research. Third-party tested, documented per batch.

(505) 460-8488

[email protected]

Shop

  • All Products

Resources

  • Research Library
  • Certificates of Analysis
  • Affiliate Program
  • Loyalty Program
  • Refer a Friend

Support

  • Contact Us
  • FAQ
  • Shipping Info
  • Returns & Refunds

Legal

  • Privacy Policy
  • Your Privacy Choices
  • Terms of Service
  • Affiliate Terms
  • Disclaimer
  • Research Use Only

!FDA Disclaimer — Research Use Only

Statements regarding these products have not been evaluated by the U.S. Food and Drug Administration. These products are intended for laboratory and in-vitro research use only and are not for human or veterinary consumption of any kind. They are not drugs, foods, or supplements, are not FDA approved, and are not intended to diagnose, treat, cure, or prevent any disease. All products are sold exclusively to qualified researchers and must be handled by trained professionals. Read the full disclaimer →

© 2026 Luvaminos LLC. All products for research purposes only. Not for human consumption. Not FDA approved.

1209 Mountain Road PL NE STE R, Albuquerque, NM 87110

  • VisaVISA
  • Mastercard
  • American ExpressAMEX
  • DiscoverDiscover
  • Ethereum
  • SSL Secured
  • 99%+ Purity
  • Shipment Protection
Research/CJC-1295

Secretagogue

CJC-1295

A growth-hormone-releasing analog examined in preclinical secretagogue research.

Molecular Profile

Type

Synthetic peptide (GRF analogue)

Molecular formula

C165H269N47O46

Molecular weight

~3,647 g/mol

CAS number

446262-90-4 (with DAC); 863288-34-0 (no-DAC)

Amino acids

29

Modification

Tetrasubstituted GRF(1-29) with a C-terminal Lys-linked maleimidopropionyl albumin-binding group (DAC); C-terminal amide.

Mechanism & Target Class

A synthetic analogue of growth-hormone-releasing hormone (GRF 1-29) that binds the GHRH receptor (GHRHR), a class B GPCR on pituitary somatotrophs. The DAC group enables reversible covalent binding to serum albumin. A no-DAC variant (Mod GRF 1-29; ~3,368 g/mol; PubChem CID 91976842) is also offered.

Research Focus

Studied in GHRH-receptor pharmacology and growth-hormone / IGF-1 axis research.

Storage & Handling

Lyophilized

-20°C

typically stable 24-36 months desiccated and protected from light.

Reconstituted

2-8°C for short-term use

-20°C/-80°C for longer storage.

Avoid freeze-thaw; aliquot; protect from light and moisture. The DAC maleimide group is thiol-reactive.

References

Clinical

  1. 1

    Teichman SL, et al. (2006). J Clin Endocrinol Metab — GH/IGF-1 stimulation study in healthy adults (DAC variant)

    DOI: 10.1210/jc.2005-1536PubMed 16352683
  2. 2

    Ionescu M, Frohman LA. (2006). J Clin Endocrinol Metab — GH pulsatility under continuous stimulation (DAC variant)

    DOI: 10.1210/jc.2006-1702PubMed 17018654

Primary research

  1. 3

    Timms M, et al. (2019). Drug Test Anal — LC-MS/MS confirmation in equine plasma (DAC variant)

    DOI: 10.1002/dta.2599PubMed 30938069
  2. 4

    Timms M, et al. (2019). Drug Test Anal — Immuno-PCR screen in equine plasma (DAC variant)

    DOI: 10.1002/dta.2554PubMed 30489688
  3. 5

    Henninge J, et al. (2010). Drug Test Anal — Identification in an unknown preparation (DAC variant)

    DOI: 10.1002/dta.233PubMed 21204297
  4. 6

    Sackmann-Sala L, et al. (2009). Growth Horm IGF Res — Serum-proteome-changes study (DAC variant)

    DOI: 10.1016/j.ghir.2009.03.001PubMed 19386527
  5. 7

    Alba M, et al. (2006). Am J Physiol Endocrinol Metab — GHRH-knockout mouse model (DAC variant)

    DOI: 10.1152/ajpendo.00201.2006PubMed 16822960
  6. 8

    Jetté L, et al. (2005). Endocrinology — Lead-identification study (in vitro + rat PK; DAC variant)

    DOI: 10.1210/en.2004-1286PubMed 15817669

Primary Database

PubChem CID 91971820↗

Also known as: CJC-1295 with DAC, DAC:GRF, Mod GRF 1-29 (no-DAC variant)

Research Use Only

These products are intended for research purposes only and are not for human consumption. Not FDA approved. Not intended to diagnose, treat, cure, or prevent any disease.